The Non-Malignant Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ISTH 2023 | Exigency sub-study: supporting patients with hemophilia when gene therapy is not an option
In this video, Simon Fletcher, MA, BA (Hons), Dip N, RGN , Haemnet / Oxford University Hospitals NHS Foundation Trust, Oxford, UK, briefly discusses the challenges of approaching patients with hemophilia who are unable to undergo gene therapy, emphasizing the importance of providing psychological support throughout the entire process. This interview took place at the 31st Congress of the International Society on Thrombosis and Haemostasis (ISTH), held in Montréal, Canada.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
